EGFR and neoplasm: Moreover, compared to monotherapies, this combination demonstrated more effective cytolytic ability in MDA‐MB‐231 tumour cells and longer lifespan of mice intracranially pre‐inoculated with EGFR‐expressing MDA‐MB‐231 cells.198